logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore

prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Amrutanjan Health Care Ltd

Amrutanjan Health Care

Small Cap634 EmployeesIPO 2009
Current Price
513.10
-5.2 (-1%)Updated
NSE :AMRUTANJAN
BSE :590006
Today's Range
505
513.10
indicator
523.95
52 Week Range
52W Low514.45
52W High790.95
513.10
indicator
Downside-0.26%
Upside54.15%

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
1,785.26 Cr
Market Cap
Total market value of company
P/E Ratio
31.27
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
6.03
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
19.61
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
8.72%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
31.40%
ROCE
Return on Capital Employed. >15% is good
Net Margin
12.07%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
15.41%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
12.28%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
-%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
-%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.01
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
112.97
Book Value
Net asset value per share
Dividend Yield
0.75%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
46.50%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • Robust ROE of 20% indicates efficient profit generation from equity.
  • High ROCE of 31.4% demonstrates effective capital utilization and superior returns.

Weaknesses

5 points
  • Significantly high P/E ratio (105.00) suggests potential overvaluation, posing investment risk.
  • Inconsistent quarterly profit performance raises concerns about earnings stability and predictability.

Opportunities

5 points
  • Resilient healthcare sector offers long-term growth potential from increasing demand.
  • Relatively small market cap (₹2143 Cr) offers significant market share expansion headroom.

Threats

5 points
  • Intense competition from larger players may limit market share and pricing power.
  • High P/E (105.00) versus sector (38.63) risks valuation corrections.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
S Jeyakanth
28 May 202529 May 2025156
1,400
₹716.28SELL

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4560.93+₹47.83+9.32%
R3541.98+₹28.88+5.63%
R2532.97+₹19.87+3.87%
R1523.03+₹9.93+1.94%
PIVOT514.020.920.18%
CURRENT513.10--
S1466.18-₹46.92-9.14%
S2485.13-₹27.97-5.45%
S3495.07-₹18.03-3.51%
S4504.08-₹9.02-1.76%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.28L
(19 Mar 2026)
+77.2% vs avg
Delivery %
56.8%
(19 Mar 2026)
-6.2% vs avg
Avg Volume (20D)
0.16L
(19 Feb - 19 Mar)
20-day average
Avg Delivery %
63.0%
(19 Feb - 19 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Sun Pharmaceutical Industries Ltd
4.12L ₹ Cr
Best Profit Growth
Ind-Swift Laboratories Ltd
833.00 %
Highest Dividend Yield
Jagsonpal Pharmaceuticals Ltd
1.44 %

Peer Comparison

Company Name
BAJAJHCARE
Bajaj Healthcare Ltd
BETA
Beta Drugs Ltd
BLISSGVS
Bliss GVS Pharma Ltd
HIKAL
Hikal Ltd
INDOCO
Indoco Remedies Ltd
INDSWFTLAB
Ind-Swift Laboratories Ltd
IOLCP
IOL Chemicals & Pharmaceuticals Ltd
JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd
LINCOLN
Lincoln Pharmaceuticals Ltd
MOREPENLAB
Morepen Laboratories Ltd
NGLFINE
NGL Fine Chem Ltd
SMSPHARMA
SMS Pharmaceuticals Ltd
SUNPHARMA
Sun Pharmaceutical Industries Ltd
SYNCOMF
Syncom Formulations (India) Ltd
TTKHLTCARE
TTK Healthcare Ltd

About

AMRUTANJAN

Amrutanjan Health Care Ltd

Amrutanjan Health Care Limited is a prominent Indian company specializing in the manufacture, supply, and sale of Ayurvedic pain relief balms and women's hygiene products. Established in 1893 and headquartered in Chennai, the company has a long history of providing healthcare solutions. Originally known as Amrutanjan Limited, it rebranded to its current name in 2007, reflecting its expansion beyond its core product line.

The company's business is segmented into three key areas: OTC (Over-the-Counter) Products, Beverages, and Others. The OTC Products segment is the largest, encompassing a wide range of pain management solutions. This includes various pain balms and roll-ons targeting different pain types (back pain, body pain, joint pain), as well as stick-on patches, gels, and sprays. Furthermore, they offer congestion management products such as cold rubs, cough syrups, nasal inhalers, and throat lozenges. Their women's hygiene product line features sanitary napkins.

Beyond pain relief and women's health, Amrutanjan also operates in the beverage sector under the Fruitnik and Fruitnik Electro+ brands, offering juice drinks. The "Others" segment encompasses a diverse array of products including corn caps, dental gel, and hand sanitizers. Interestingly, the company also manages a pain management center, demonstrating a commitment to comprehensive healthcare services.

Amrutanjan's reach extends beyond the domestic Indian market, with significant export activities to various regions globally. These export markets include the Middle East, Africa, and Southeast Asia, highlighting the international appeal of their products and brand reputation. The company's success stems from a blend of traditional Ayurvedic formulations and modern manufacturing practices, catering to a broad consumer base seeking effective and accessible healthcare solutions.

COMPANY FACTS - AMRUTANJAN

Registered Address

103, (Old No. 42-45),, Luz Church Road. Mylapore,

Chennai

TAMIL NADU

IN

Company Details

Group: Pharmaceuticals, Biotechnology & Life Sciences

Sector: Health Care

Industry: Pharmaceuticals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 634

IPO Date: 05/11/2009

MANAGEMENT - AMRUTANJAN

Mr. S. Sambhu Prasad

Executive Chairman of the Board, Managing Director

Mr. N. Swaminathan

Chief Financial Officer

Mr. Mani Bhagavatheeswaran

Chief Marketing Officer

Mr. M. Srinivasan

Compliance Officer, Company Secretary

Mr. Soumomoy Pal

General Manager - Information Technology

Dr. J. Ravichandran

General Manager - QC/QA/R&D

Mr. S. Jeyakanth

Chief Operating Officer - Supply Chain and Product Delivery

Mr. R. Narayanan

Chief Sales Officer

Ms. Ramaa Arikirevula

Non-Executive Director

Mr. Govindan Raghavan

Non-Executive Director

Ms. Meenalochani Raghunathan

Non-Executive Independent Director

Mr. Muralidharan Swayambunathan

Non-Executive Independent Director

Investor Questions Answered

Amrutanjan Health Care Ltd (AMRUTANJAN) Stock FAQs

Get answers to the most common questions about Amrutanjan Health Care Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹513.1. Today, the stock has declined by ₹5.20 (1.00%), trading in a range of ₹505 to ₹523.95. The stock opened at ₹514 with a trading volume of 27,760 shares.
Amrutanjan Health Care Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,785.26 crores, P/E ratio of 31.27, ROE of 8.72%, and ROCE of 31.40%. The dividend yield stands at 0.75%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹790.95, while the 52-week low is ₹514.45. Currently trading at ₹513.1, the stock is -0.5% away from its 52-week low and 35.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Amrutanjan Health Care Ltd stock at ₹513.1 depends on multiple factors. The stock is currently trading with a P/E ratio of 31.27 and P/B ratio of N/A. Today's performance shows a loss of 1.00%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Amrutanjan Health Care Ltd offers a dividend yield of 0.75%, which means for every ₹100 invested at the current price of ₹513.1, you can expect to receive approximately ₹0.75 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Amrutanjan Health Care Ltd's key financial metrics include: P/E Ratio: 31.27, P/B Ratio: N/A, ROE: 8.72%, ROCE: 31.40%, Dividend Yield: 0.75%, EPS: ₹19.61, Book Value: ₹112.97, Debt-to-Equity: 0.01, and Current Ratio: N/A. The company's market cap stands at ₹1,785.26 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Amrutanjan Health Care Ltd stock opened at ₹514 and is currently trading at ₹513.1, showing a decline of ₹5.20 (1.00%). The intraday high is ₹523.95 and low is ₹505. The trading volume stands at 27,760 shares, indicating moderate market participation today.
Amrutanjan Health Care Ltd has a Price-to-Earnings (P/E) ratio of 31.27, which means investors are willing to pay ₹31.27 for every ₹1 of earnings. With an EPS of ₹19.61, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Amrutanjan Health Care Ltd has a market capitalization of ₹1,785.26 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹513.1) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Amrutanjan Health Care Ltd has a book value of ₹112.97 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹513.1, which is 354.2% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Amrutanjan Health Care Ltd has a Return on Equity (ROE) of 8.72% and Return on Capital Employed (ROCE) of 31.40%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Amrutanjan Health Care Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Amrutanjan Health Care Ltd has a debt-to-equity ratio of 0.01, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Amrutanjan Health Care Ltd has an Earnings Per Share (EPS) of ₹19.61, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹513.1 and P/E ratio of 31.27, investors are paying 31.27 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Amrutanjan Health Care Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Amrutanjan Health Care Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Amrutanjan Health Care Ltd stock, consider: 1) Fundamental Analysis - Review P/E (31.27), ROE (8.72%), debt-to-equity (0.01), and growth rates. 2) Technical Analysis - Check 52-week range (₹514.45 - ₹790.95), moving averages, and chart patterns. 3) Valuation - Compare current price (₹513.10) with book value (₹112.97) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Amrutanjan Health Care Ltd share is ₹1.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹513.1 is 51210x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Amrutanjan Health Care Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹514.45 - ₹790.95). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.01 indicates leverage. 4) Liquidity Risk - Based on trading volume of 27,760 shares. 5) Valuation Risk - P/E of 31.27 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Amrutanjan Health Care Ltd operates in the industry with key metrics: P/E ratio of 31.27, ROE of 8.72%, market cap of ₹1,785.26 crores, and dividend yield of 0.75%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.01), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Amrutanjan Health Care Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹513.1, with a 52-week range of ₹514.45 to ₹790.95. Based on fundamentals like P/E (31.27), ROE (8.72%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Amrutanjan Health Care Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹513.10. 2) Fundamental Deterioration - Declining ROE (currently 8.72%), increasing debt (D/E: 0.01), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Amrutanjan Health Care Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.75%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.